Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
2.390
-0.140 (-5.53%)
Nov 21, 2024, 1:54 PM EST - Market open
Sana Biotechnology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 537 | 804 | 750 | 2,833 | - | - | |
| Market Cap Growth | 21.43% | 7.21% | -73.52% | - | - | - | |
| Enterprise Value | 462 | 633 | 350 | 2,066 | - | - | |
| Last Close Price | 2.53 | 4.08 | 3.95 | 15.48 | - | - | |
| PB Ratio | 1.93 | 2.80 | 1.50 | 3.89 | - | - | |
| P/TBV Ratio | 9.99 | 9.17 | 2.50 | 5.36 | - | - | |
| Debt / Equity Ratio | 0.33 | 0.36 | 0.22 | 0.15 | 0.17 | 0.17 | |
| Quick Ratio | 4.23 | 3.18 | 3.80 | 5.55 | 12.03 | 7.19 | |
| Current Ratio | 4.47 | 3.31 | 3.99 | 5.62 | 12.22 | 7.47 | |
| Return on Equity (ROE) | -92.90% | -72.00% | -43.90% | -61.36% | -80.76% | -85.10% | |
| Return on Assets (ROA) | -31.15% | -29.44% | -16.82% | -21.85% | -28.41% | -34.28% | |
| Return on Capital (ROIC) | -43.58% | -40.90% | -22.70% | -30.25% | -39.39% | -43.41% | |
| Earnings Yield | -57.91% | -35.22% | -35.92% | -12.56% | - | - | |
| FCF Yield | -52.08% | -34.02% | -41.45% | -9.91% | - | - | |
| Buyback Yield / Dilution | -14.69% | -3.29% | -13.17% | -1178.88% | -165.43% | -415.02% | |
| Total Shareholder Return | -14.69% | -3.29% | -13.17% | -1178.88% | -165.43% | -415.02% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.